Endocrinological late effects after chemotherapy for testicular cancer
1996

Endocrinological Effects After Chemotherapy for Testicular Cancer

Sample size: 63 publication Evidence: moderate

Author Information

Author(s): CC Berger, C Bokemeyer, F Schuppert, H-J Schmoll

Primary Institution: Hannover University Medical School

Hypothesis

What are the long-term endocrinological effects of cisplatin-based chemotherapy in survivors of testicular cancer?

Conclusion

Major endocrinological abnormalities persist in more than half of young patients cured from testicular cancer by cisplatin-based combination chemotherapy.

Supporting Evidence

  • 63% of patients had elevated FSH levels after chemotherapy.
  • 24% of patients showed elevated LH levels.
  • 68% of patients had elevated DHEA levels.
  • 32% of patients had elevated cholesterol levels.

Takeaway

This study found that many young men who survived testicular cancer treatment still have hormone problems years later, which could affect their health.

Methodology

The study included 63 long-term disease-free survivors of testicular cancer who underwent blood tests to assess hormone levels after cisplatin-based chemotherapy.

Potential Biases

Potential biases may arise from the retrospective nature of the study and the selection of participants.

Limitations

The study did not include patients with certain pre-existing conditions, which may limit the generalizability of the findings.

Participant Demographics

Median age of participants was 30 years, with a follow-up period of 42 months.

Statistical Information

P-Value

0.006 for FSH, 0.01 for LH

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication